Zuowei Zhao

Dalian Medical University — China

Medicine · Health Sciences

19h-index1.2kcitations72works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(13), Breast Cancer Treatment Studies(11), HER2/EGFR in Cancer Research(9), Cancer Genomics and Diagnostics(9), Breast Lesions and Carcinomas(7)

Publications72 total

The efficacy and safety of sacituzumab govitecan in the treatment of breast cancer: a systemic review and meta-analysis of emerging clinical data
Frontiers in Immunology·2025Open Access
Bioinformatics analysis of IFI6 as a novel prognostic biomarker and its correlation with immune infiltration in breast cancer
Scientific Reports·2025Open Access
Intra-tumoral microbial heterogeneity of breast cancer: roles in tumorigenesis, therapeutic responses, and future directions
Journal of Applied Microbiology·2025· 2 cited
Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world study
iScience·2025Open Access
Mucinous breast cancer organoids: an in vitro research model
Discover Oncology·2025· 1 citedOpen Access
Options after progression on first-line CDK4/6 inhibitors in advanced breast cancer patients
Therapeutic Advances in Medical Oncology·2025· 3 citedOpen Access
Organoids as a model system for researching human neuroendocrine tumor of the breast
Cancer Cell International·2024· 2 citedOpen Access
The Burden of Peripheral Artery Disease in China From 1990 to 2019 and Forecasts for 2030: Findings From the Global Burden of Disease Study 2019
International Journal of Public Health·2024· 3 citedOpen Access
STIL facilitates the development and malignant progression of triple-negative breast cancer through activation of Fanconi anemia pathway via interacting with KLF16
Translational Oncology·2024· 3 citedOpen Access
A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012)
Frontiers in Oncology·2024· 1 citedOpen Access
PARP Inhibitor for Neoadjuvant Therapy in HER2-Negative Breast Cancer: A Systematic Review and Meta-Analysis of Efficacy and Safety
Clinical Breast Cancer·2024· 6 citedOpen Access
mTOR inhibitor introduce disitamab vedotin (RC48-ADC) rechallenge microtubule-chemotherapy resistance in HER2-low MBC patients with PI3K mutation
Frontiers in Oncology·2024· 5 citedOpen Access
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?
The Breast·2024· 6 citedOpen Access
Comprehensive review of solid tumor bone marrow metastasis
Critical Reviews in Oncology/Hematology·2023· 7 cited
Association of a complete breast cancer pathologic response with axillary lymph node metastasis via neoadjuvant chemotherapy: Results from the CSBrS-012 study
Chinese Medical Journal·2023· 4 citedOpen Access
Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapy
Journal of Cancer Research and Clinical Oncology·2023Open Access
Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapy
Research Square (Research Square)·2023Open Access
Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)
Therapeutic Advances in Medical Oncology·2023· 3 citedOpen Access
A systematic review and meta-analysis of BRCA1/2 mutation for predicting the effect of platinum-based chemotherapy in triple-negative breast cancer
The Breast·2022· 16 citedOpen Access
The Notch Signaling Pathway Contributes to Angiogenesis and Tumor Immunity in Breast Cancer
Breast Cancer Targets and Therapy·2022· 24 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Xuelu Li(15), Caigang Liu(14), Hao Zhang(8), Jiyue Gao(8), Man Li(8), Siwen Sun(7), Kainan Wang(6), Chen Song(6), Man Li(5), Man Li(5), Bo Pan(5), Man Li(5), Ping Lu(4), Dongyi Zhao(4), Dan Wang(3), Minna Luo(3), Xin Zhang(3), Ningning Gao(3), Guanglei Chen(3), Gena Huang(3)